Fundraising Fox
/Companies
Sign in

Mercy BioAnalytics

Natick, US · Founded 2018 · 64 employees on LinkedIn · 9 known investors

Find your way into Mercy BioAnalytics

Sign up to see every warm intro you have to Mercy BioAnalytics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Mercy BioAnalytics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Mercy BioAnalytics develops diagnostic tests for early cancer detection using advanced proteomics and genomics technologies. The company serves healthcare providers and patients seeking to improve cancer detection accuracy and timing.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

Mercy BioAnalytics was founded in 2018 by Paul Blavin and Stanley Lapidus.

PB
Paul BlavinCo-Founder & Vice ChairmanPaul Blavin is co-founder and Vice Chairman of Mercy BioAnalytics, which develops diagnostic tests for early cancer detection. He co-founded the Blavin Scholars in 2003, a nonprofit supporting individuals with foster care or homelessness experience in pursuing post-secondary education.
SLStanley Lapidus
Stanley LapidusCo-founder · Chairman, Board or DirectorsCEO, SynapDX & Founding Pillar at Pillar VC
DM
Dawn Mattoon, PhDChief Executive Officer
JS
Joseph SedlakExecutive

Board

PMPaul Meister
Paul MeisterBoard directorPartner at Novalis LifeSciences
SHSonja Hoel Perkins
Sonja Hoel PerkinsBoard directorManaging Director at The Perkins Fund

Investors · 9

Hatteras Venture Partnerslisted by Hatteras Venture PartnersResearch Triangle · $500K – $4M

How we know: Hatteras Venture Partners's portfolio page · Not right? Tell us

iSelect Fundlisted by iSelect FundSt. Louis · $250K – $2M
Mindshift Capitallisted by Mindshift CapitalDubai
Novalis LifeScienceslisted by Novalis LifeSciencesPortsmouth

How we know: board seat on SEC Form D · Not right? Tell us

Portfolialisted by PortfoliaSan Mateo

How we know: Portfolia's portfolio page · the VCSheet dataset · Not right? Tell us

Sozo Ventureslisted by Sozo VenturesRedwood City

How we know: Sozo Ventures's portfolio page · funding news · Not right? Tell us

The Perkins Fundlisted by The Perkins Fundvia Sonja Perkins · inferred
BrightEdgereportedAtlanta

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Funding

SEC filings, press & company announcements

$68.3M disclosed across 2 of 4 rounds · 2020–2025

▶$27.3MraisedFeb 2021 · 57 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul BlavinExecutive Officer, Director
  • Joseph SedlakExecutive Officer, Director
  • Stanley LapidusDirector
  • Paul MeisterDirector
  • Sonja Hoel PerkinsDirector
Offering amount
$27.3M
Amount sold
$27.3M
First sale
Nov 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Mercy BioAnalytics went on to found or lead other companies.

Stan LapidusDirectorFounded Exact SciencesMyla Lai-GoldmanBoard MemberFounded GeneCentricSarah KalilAdvisorFounded CoreMap

In the news

Mercy BioAnalytics Announces $59 Million Series B Financing to Advance Early Cancer Detection Programs - Mercy BioAnalyticsmercybio.com · Sep 2025Mercy BioAnalytics Raises $41M in Series A Fundingfinsmes.com · Apr 2023

Frequently asked questions

What does Mercy BioAnalytics do?
Mercy BioAnalytics develops diagnostic tests for early cancer detection using advanced proteomics and genomics technologies. The company serves healthcare providers and patients seeking to improve cancer detection accuracy and timing.
Who founded Mercy BioAnalytics?
Mercy BioAnalytics was founded by Paul Blavin, Stanley Lapidus in 2018.
Who are Mercy BioAnalytics's investors?
Mercy BioAnalytics's investors include Avestria Ventures, Hatteras Venture Partners, iSelect Fund, Mindshift Capital, Novalis LifeSciences, Portfolia, Sozo Ventures, The Perkins Fund and 1 more.
How much funding has Mercy BioAnalytics raised?
Mercy BioAnalytics has disclosed $68.3M raised across 2 of its 4 known rounds.
Where is Mercy BioAnalytics headquartered?
Mercy BioAnalytics is headquartered in Natick, US.